Peter Greenleaf

Peter Greenleaf

Chief Executive Officer at AURINIA PHARMACEUTICALS INC.

Net worth: 2 M $ as of 2024-04-29

54 year
Health Technology
Commercial Services
Finance

Profile

Peter S.
Greenleaf
is currently the President & Chief Executive Officer at Aurinia Pharmaceuticals, Inc. He is also the Chairman at Maryland Venture Fund and Revolo Biotherapeutics Ltd.
Additionally, he holds positions as a Director at Pharmaceutical Research & Manufacturers of America, ValenzaBio, Inc., and Petrichor Healthcare Capital Management LP.
In his former roles, Mr. Greenleaf served as the President, Chief Executive Officer & Director at Histogenics Corp.
from 2013 to 2014.
He was also the Chairman & Chief Executive Officer at Sucampo Pharmaceuticals LLC from 2014 to 2018.
Furthermore, he held the position of Chairman at BioDelivery Sciences International, Inc. and Antares Pharma, Inc. from 2018 to 2022.
Mr. Greenleaf has a strong educational background, having obtained an MBA from St. Joseph's University and an undergraduate degree from Western Connecticut State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-29 311,558 ( 0.22% ) 2 M $ 2024-04-29

Peter Greenleaf active positions

CompaniesPositionStart
AURINIA PHARMACEUTICALS INC. Chief Executive Officer 2019-04-28
Consultant / Advisor -
Chairman 2020-12-16
Director/Board Member -
Chairman -
Director/Board Member -
All active positions of Peter Greenleaf

Former positions of Peter Greenleaf

CompaniesPositionEnd
ANTARES PHARMA, INC. Director/Board Member 2022-05-23
BIODELIVERY SCIENCES INTERNATIONAL, INC. Chairman 2022-03-21
AVALO THERAPEUTICS, INC. Chief Executive Officer 2019-04-14
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Peter Greenleaf's experience

Training of Peter Greenleaf

St. Joseph's University Masters Business Admin
Western Connecticut State University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Greenleaf's experience

Connections

99

1st degree connections

31

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
KIORA PHARMACEUTICALS, INC.

Health Technology

AVALO THERAPEUTICS, INC.

Health Technology

AURINIA PHARMACEUTICALS INC.

Health Technology

SAVARA INC.

Health Technology

Private companies25

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

LigoCyte Pharmaceuticals, Inc.

Health Technology

The University of Maryland Baltimore Foundation, Inc.

Miscellaneous

Finance

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Peter Greenleaf